CI
VRCA icon

Conning Inc’s Verrica Pharmaceuticals VRCA Stock Holding History

Conning Inc’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,901
Closed -$355K – 379
2022
Q4 		$355K Buy
+12,901
New +$344K 0.01% 274
2020
Q1 		– Sell
-12,901
Closed -$2.05M – 469
2019
Q4 		$2.05M Hold
12,901
– – 0.07% 145
2019
Q3 		$1.9M Hold
12,901
– – 0.07% 158
2019
Q2 		$1.5M Hold
12,901
– – 0.05% 177
2019
Q1 		$1.4M Hold
12,901
– – 0.04% 209
2018
Q4 		$1.05M Hold
12,901
– – 0.04% 226
2018
Q3 		$2.1M Sell
12,901
-172
-1% -$29.4K 0.06% 174
2018
Q2 		$2.58M Buy
+13,073
New +$2.56M 0.08% 167

Other funds holding VRCA

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return